Company / Total Assets
Ernexa Therapeutics Inc. Total Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$5.8M
FY2025
5-year range
$3.7M / $49.1M
FY2021-FY2025
Trend
+10.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $4M in FY2020 to $49M in FY2023.
Based on SEC 10-K filings.
$6M in FY2025 with a 10-year CAGR of -9.8%.
Declined from $49M to $6M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +9.3%
- 10-Year CAGR
- -9.8%
Key checks
Key Insights
- 5-year CAGR of +9.3%, indicating consistent growth.
- In FY2025, total assets increased 10.7% year-over-year.
- Peak total assets was recorded in FY2023.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | +10.7% |
| FY2024 | $5.3M | -89.3% |
| FY2023 | $49.1M | +1211.9% |
| FY2020 | $3.7M | -73.5% |
| FY2019 | $14.1M | -5.0% |
| FY2018 | $14.9M | -10.3% |
| FY2017 | $16.6M | -0.7% |
| FY2016 | $16.7M | +1.7% |
| FY2015 | $16.4M | -26.3% |
| FY2014 | $22.3M | +44.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026